RAOUL KEMZEU

Mr. RAOUL KEMZEU

Biochemistry, Université de Yaoundé I, Yaoundé, Centre, Cameroon
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
GNGabrielle Ange Amang À Ngnoung
Gabrielle Ange Amang À Ngnoung
LSLazare S. Sidjui
Lazare S. Sidjui
BOSCO PERON LEUTCHABOSCO PERON LEUTCHA
BOSCO PERON LEUTCHA
YNYves Oscar Nganso
Yves Oscar Nganso
LYLauve Rachel Tchokouaha Yamthe
Lauve Rachel Tchokouaha Yamthe
BNBarthelemy Nyasse
Barthelemy Nyasse
Antrocaryon klaineanum is traditionally used for the treatment of back pain, malaria, female sterility, chlamydiae infections, liver diseases, wounds, and hemorrhoid. This work aimed at investigating the bioactive compounds with antileishmanial and antiplasmodial activities from A. klaineanum. An unreported glucocerebroside antroklaicerebroside (1) together with five known compounds (2–6) were isolated from the root barks of Antrocaryon klaineanum using chromatographic techniques. The NMR, MS, and IR spectroscopic data in association with previous literature were used for the characterization of all the isolated compounds. Compounds 1–4 are reported for the first time from A. klaineanum. The methanol crude extract (AK-MeOH), the n-hexane fraction (AK-Hex), the dichloromethane fraction (AK-DCM), the ethyl acetate fraction (AK-EtOAc), and compounds 1–6 were all evaluated for their antiparasitic effects against Plasmodium falciparum strains susceptible to chloroquine (3D7), resistant to chloroquine (Dd2), and promastigotes of Leishmania donovani (MHOM/SD/62/1S). The AK-Hex, AK-EtOAc, AK-MeOH, and compound 2 were strongly active against Dd2 strain with IC50 ranging from 2.78 ± 0.06 to 9.30 ± 0.29 µg/mL. Particularly, AK-MeOH was the most active—more than the reference drugs used—with an IC50 of 2.78 ± 0.06 µg/mL. The AK-EtOAc as well as all the tested compounds showed strong antileishmanial activities with IC50 ranging from 4.80 ± 0.13 to 9.14 ± 0.96 µg/mL.

28 July 2025 in Exploration of Drug Science
Verified
Journal Article
Open access
PDF file
PFPatrick Valere Tsouh Fokou
Patrick Valere Tsouh Fokou
CMCourthney Akwi Mboh
Courthney Akwi Mboh
KNKenneth Lifoter Navti
Kenneth Lifoter Navti
MNMarius Jaurès Tsakem Nangap
Marius Jaurès Tsakem Nangap
RKRAOUL KEMZEU
RAOUL KEMZEU
FBFabrice Fekam Boyom
Fabrice Fekam Boyom
Aim: This study evaluates the in vitro and in vivo antiplasmodial, hemolytic, and antioxidant activities of a combined extract of Ageratum conyzoides (A. conyzoides) and Bidens pilosa (B. pilosa), a traditionally used but scientifically unvalidated combination. Methods: Plant leaves were extracted via aqueous decoction and cold maceration, combining equal parts to mimic traditional preparation. In vitro antiplasmodial activity against the chloroquine-sensitive Plasmodium falciparum 3D7 (Pf3D7) strain was assessed using the SYBR Green I assay. Cytotoxicity was evaluated via hemolysis test, and antioxidant potential using DPPH (2,2-diphenyl-1-picrylhydrazyl), ABTS [2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)], and FRAP (ferric ion reducing antioxidant potential) assays. The most potent combination was tested for acute toxicity and curative antimalarial activity in a rodent model. Results: Extract yields ranged from 6.6% (cold maceration extract of B. pilosa) to 29.2% [aqueous decoction extract of combination (Cd)]. Extracts showed moderate to mild in vitro antiplasmodial activity [IC50 (median inhibitory concentration): 24.8–96.6 µg/mL], with the aqueous Cd showing potential synergism [CI (combination index) < 1]. No significant cytotoxicity was observed (< 10% hemolysis). Moderate to good antioxidant activity was found in DPPH [SC50 (median scavenging concentration): 134.65–307.55 µg/mL] and ABTS assays (SC50: 92.23–183.45 µg/mL), with Cd showing the highest activity. FRAP values were low. The Cd extract demonstrated no significant acute toxicity up to 5,000 mg/kg and significant in vivo antimalarial activity, achieving 65% parasite inhibition at 200 mg/kg/day. It also prolonged survival time, with a maximum survival of 28 days at 200 mg/kg/day. Conclusions: This preliminary investigation suggests that combined extracts of A. conyzoides and B. pilosa exhibit noteworthy in vitro and in vivo antiplasmodial activity against the tested strains. Further studies are warranted to validate these findings and develop optimized formulations as potential antimalarials.

1 January 2022 in Journal of Phytomolecules and Pharmacology
Verified
Journal Article
Closed access
IBIssakou Bakarnga-Via
Issakou Bakarnga-Via
NBNadlaou Bessimbaye
Nadlaou Bessimbaye
PFPatrick Valere Tsouh Fokou
Patrick Valere Tsouh Fokou
LYLauve Rachel Tchokouaha Yamthe
Lauve Rachel Tchokouaha Yamthe
JFJean Bapatis Hzounda Fokou
Jean Bapatis Hzounda Fokou
CMChantal Menut
Chantal Menut
The Journal of Phytomolecules & Pharmacology (JPP) is a peer-reviewed journal that brings out original research papers, reviews and short communications on the natural product & derivatives, phytoconstituents, and biological & pharmacological investigations of the extracts and products. The journal specifically invites interdisciplinary articles on phytochemistry, biotechnological approach for phytomedicines, biological and toxicological mechanisms of action, structure and bioactivity of phytochemicals (bioinformatics/computational methods).

11 September 2025 in Pharmaceutical Science Advances
Verified
Journal Article
Open access
VNVincent Ngouana
Vincent Ngouana
PFPatrick Valere Tsouh Fokou
Patrick Valere Tsouh Fokou
MNMarius Jaures Tsakem Nangap
Marius Jaures Tsakem Nangap
RKRAOUL KEMZEU
RAOUL KEMZEU
AYAubin Kamche Youbi
Aubin Kamche Youbi
FBFabrice Fekam Boyom
Fabrice Fekam Boyom
Malaria remains a major global health issue, particularly in endemic regions. Traditional medicine offers promising remedies, such as Melochia umbellata, a plant used in Cameroonian folk medicine for malaria treatment. While its in vitro antiplasmodial activity has been reported, the safety and curative efficacy of M. umbellata aqueous leaf extract (MULAE) in vivo required further investigation. This study evaluated the curative antimalarial and hepato-renal protective effects of MULAE in a Plasmodium berghei-infected rat model, alongside its phytochemical characterization. Qualitative and quantitative analyses confirmed the presence of pharmacologically active secondary metabolites, including alkaloids, phenols, flavonoids, and saponins. In acute toxicity tests (OECD guideline 423), female rats received single oral doses of MULAE (2000, 5000 ​mg/kg). No mortality or signs of toxicity were observed throughout the 14-day monitoring period, indicating an LD50 greater than 5000 ​mg/kg. For the curative assay, P. berghei-infected rats were treated for five days with MULAE (100, 200, 400 ​mg/kg), chloroquine (10 ​mg/kg), or distilled water. MULAE significantly suppressed parasitemia dose-dependently; the 400 ​mg/kg dose achieved 86.20% chemosuppression. The extract also improved hematological markers (restoring hemoglobin levels to 14.9 ​g/dL at 400 ​mg/kg), mitigated infection-induced weight loss, and reduced organ damage. This organ protection was evidenced by improved blood serum markers (creatinine, ALAT, ASAT, bilirubin, total protein), restored oxidative status, and ameliorated histopathological changes in the liver, kidneys, and spleen. These findings validate the traditional use of M. umbellata and support its potential as a source for novel antimalarial and organ-protective agents.

29 February 2024
Verified
Book Chapter
Closed access
PDF file
PFPatrick Valere Tsouh Fokou
Patrick Valere Tsouh Fokou
VNVincent Ngouana
Vincent Ngouana
RKRAOUL KEMZEU
RAOUL KEMZEU
AKAubin Kamche
Aubin Kamche
IBIssakou Bakarnga-Via
Issakou Bakarnga-Via
The Periplocoididae subfamily of the Apocynaceae family contains the genus Cryptolepis. With 30 species and a vast distribution, Cryptolepis is the second biggest genus in the Periplocoideae subfamily. It has long been a staple of conventional medicine and has gained popularity for its potential as a complementary therapy for a range of medical issues. The most researched species, Cryptolepis sanguinolenta, has historically been used in West Africa to treat respiratory ailments, diarrhoea, and malaria. Cryptolepis sanguinolenta, a plant renowned for its antimalarial qualities, yields cryptolepine, a monomeric heterocyclic indoloquinoline conjugate. Its pharmacological features, which include the potential for utilizing it to treat Alzheimer’s disease, diabetes, hypertension, hepatitis B virus infection, cancers, and liver damage, as well as its antibacterial and antifungal capabilities, have all been studied. This chapter discusses the pharmacology of Cryptolepis, its advantages for treating malaria, and any possible drawbacks. <!----> <!----> <!----> <!---->

29 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
FBFrank Lilian Mahel Batana
Frank Lilian Mahel Batana
VNVincent Ngouana
Vincent Ngouana
EKEugenie Aimée Madiesse Kemgne
Eugenie Aimée Madiesse Kemgne
PBPone Kamdem Boniface
Pone Kamdem Boniface
MNMarius Jaures Tsakem Nangap
Marius Jaures Tsakem Nangap
FBFabrice Fekam Boyom
Fabrice Fekam Boyom
Background: Malaria is a parasitic disease that affects many parts of the globe, especially sub-Saharan Africa. Over time, malaria parasites have become resistant to most antimalarial drugs, including artemisinin. Medicinal plants, which are used in the traditional treatment of malaria can afford effective drugs against this notorious disease. One such plant includes Vernonia blumeoides, which is used in the treatment of parasitic diseases, including malaria. Thus the scientific validation of the use of Vernonia blumeoides in ethnomedicine is of outstanding importance. Objectives: This study sought to investigate the antiplasmodial and antioxidant activity of extracts from Vernonia blumeoides; Methods: Vernonia blumeoides ethanol extract was obtained by maceration, and then subjected to phytochemical screening using standard protocols. The as-prepared extract was partitioned using solvents of increasing polarity to afford hexane, ethyl acetate, n-butanol fractions, and the water residue. The antiplasmodial potential of extract and fractions was determined by the Sybr green method. Antioxidant activity of V. blumeoides extracts was evaluated using DPPH, ABTS and FRAP assays. Cytotoxicity test was performed on murine macrophage Raw cells using the resazurin test; Results: The ethanol extract was obtained as a brown powder and the yield of extraction was found to be 43.95%. The phytochemical screening of this extract revealed the presence of tannins, alkaloids, flavonoids, phenolic compounds, and glycosides. Upon antiplasmodial screening against P. falciparum Dd2 and 3D7, the median inhibitory concentrations (IC50) of extract and fractions from V. blumeoides ranged from 4.70 to >100 µg/ml, with ethyl acetate extract having the lowest IC50 value and highest activity. Vernonia blumeoides extracts exhibited antioxidant activity with median scavenging concentrations ranging from 31.17 to 124.1 µg/mL, 50.84 to 500 µg/mL, and 33.95 to 500 µg/mL for ABTS, DPPH and FRAP assays, respectively. Cytotoxicity test of V. blumeoides extracts on Raw cells revealed non toxicity; Conclusions: This novel contribution demonstrated the antiplasmodial activity of V. blumeoides extracts, thus validating the ethnopharmacological use of this plant in the treatment of malaria symptoms. Nonetheless, in depth studies on the mechanisms of action, in vivo toxicity, as well as pharmacokinetic experiments are warranted for the successful utilization of this plant in ethnomedicine.